Logo image of BLN.CA

BLACKLINE SAFETY CORP (BLN.CA) Stock Fundamental Analysis

TSX:BLN - Toronto Stock Exchange - CA0923821007 - Common Stock - Currency: CAD

6.33  -0.03 (-0.47%)

Fundamental Rating

4

Taking everything into account, BLN scores 4 out of 10 in our fundamental rating. BLN was compared to 13 industry peers in the Electronic Equipment, Instruments & Components industry. BLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BLN has reported negative net income.
BLN had a negative operating cash flow in the past year.
In the past 5 years BLN always reported negative net income.
In the past 5 years BLN reported 4 times negative operating cash flow.
BLN.CA Yearly Net Income VS EBIT VS OCF VS FCFBLN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.50%, BLN is in line with its industry, outperforming 53.85% of the companies in the same industry.
BLN has a better Return On Equity (-9.16%) than 61.54% of its industry peers.
Industry RankSector Rank
ROA -4.5%
ROE -9.16%
ROIC N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
BLN.CA Yearly ROA, ROE, ROICBLN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

BLN has a Gross Margin of 60.67%. This is amongst the best in the industry. BLN outperforms 100.00% of its industry peers.
BLN's Gross Margin has improved in the last couple of years.
BLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
BLN.CA Yearly Profit, Operating, Gross MarginsBLN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

BLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLN has been increased compared to 1 year ago.
BLN has more shares outstanding than it did 5 years ago.
BLN has a better debt/assets ratio than last year.
BLN.CA Yearly Shares OutstandingBLN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BLN.CA Yearly Total Debt VS Total AssetsBLN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 3.52 indicates that BLN is not in any danger for bankruptcy at the moment.
BLN has a worse Altman-Z score (3.52) than 61.54% of its industry peers.
BLN has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
BLN has a Debt to Equity ratio (0.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACCN/A
WACC8.33%
BLN.CA Yearly LT Debt VS Equity VS FCFBLN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 2.35 indicates that BLN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.35, BLN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
BLN has a Quick Ratio of 2.02. This indicates that BLN is financially healthy and has no problem in meeting its short term obligations.
BLN has a Quick ratio of 2.02. This is comparable to the rest of the industry: BLN outperforms 53.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.02
BLN.CA Yearly Current Assets VS Current LiabilitesBLN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

BLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.41%, which is quite impressive.
BLN shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.80%.
Measured over the past years, BLN shows a very strong growth in Revenue. The Revenue has been growing by 30.78% on average per year.
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)26.8%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%13.81%

3.2 Future

BLN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.75% yearly.
BLN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.18% yearly.
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.18%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLN.CA Yearly Revenue VS EstimatesBLN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
BLN.CA Yearly EPS VS EstimatesBLN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 129.68 indicates a quite expensive valuation of BLN.
Based on the Price/Forward Earnings ratio, BLN is valued a bit cheaper than 69.23% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.80. BLN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 129.68
BLN.CA Price Earnings VS Forward Price EarningsBLN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BLN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 341.89
BLN.CA Per share dataBLN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLN does not grow enough to justify the current Price/Earnings ratio.
BLN's earnings are expected to grow with 20.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.23%
EPS Next 3Y20.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKLINE SAFETY CORP

TSX:BLN (7/31/2025, 7:00:00 PM)

6.33

-0.03 (-0.47%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)06-11 2025-06-11/bmo
Earnings (Next)09-09 2025-09-09
Inst Owners25.71%
Inst Owner ChangeN/A
Ins Owners2.87%
Ins Owner ChangeN/A
Market Cap549.00M
Analysts80
Price Target9.33 (47.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.24%
Min EPS beat(2)-32.01%
Max EPS beat(2)72.5%
EPS beat(4)3
Avg EPS beat(4)40.75%
Min EPS beat(4)-32.01%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)6.9%
EPS beat(12)5
Avg EPS beat(12)4.19%
EPS beat(16)5
Avg EPS beat(16)-4.88%
Revenue beat(2)1
Avg Revenue beat(2)4.23%
Min Revenue beat(2)-5.5%
Max Revenue beat(2)13.97%
Revenue beat(4)2
Avg Revenue beat(4)1.63%
Min Revenue beat(4)-6.38%
Max Revenue beat(4)13.97%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)5
Avg Revenue beat(12)-0.2%
Revenue beat(16)6
Avg Revenue beat(16)-0.52%
PT rev (1m)0%
PT rev (3m)3.23%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-20%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.55%
Revenue NQ rev (3m)-2.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 129.68
P/S 3.84
P/FCF N/A
P/OCF N/A
P/B 6.82
P/tB 7.43
EV/EBITDA 341.89
EPS(TTM)-0.08
EYN/A
EPS(NY)0.05
Fwd EY0.77%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.65
BVpS0.93
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.5%
ROE -9.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.67%
FCFM N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 8.37
Cap/Depr 102.31%
Cap/Sales 6.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.02
Altman-Z 3.52
F-Score5
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)111.77%
Cap/Depr(5y)105.56%
Cap/Sales(3y)8.6%
Cap/Sales(5y)9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue 1Y (TTM)26.8%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%13.81%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.18%
EBIT growth 1Y64.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.57%
EBIT Next 3Y65.48%
EBIT Next 5Y41.81%
FCF growth 1Y82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y96.97%
OCF growth 3YN/A
OCF growth 5YN/A